1. Home
  2. BTMD vs BTCS Comparison

BTMD vs BTCS Comparison

Compare BTMD & BTCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$1.69

Market Cap

46.2M

Sector

Health Care

ML Signal

HOLD

Logo BTCS Inc.

BTCS

BTCS Inc.

HOLD

Current Price

$1.25

Market Cap

52.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTMD
BTCS
Founded
2012
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
46.2M
52.8M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
BTMD
BTCS
Price
$1.69
$1.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$2.83
$5.00
AVG Volume (30 Days)
340.6K
1.8M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
2.63%
EPS Growth
722.22
N/A
EPS
N/A
N/A
Revenue
$192,219,000.00
$16,491,584.00
Revenue This Year
$2.03
$21.23
Revenue Next Year
$6.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
304.85
52 Week Low
$1.27
$0.96
52 Week High
$3.58
$6.15

Technical Indicators

Market Signals
Indicator
BTMD
BTCS
Relative Strength Index (RSI) 51.44 49.84
Support Level $1.63 $1.00
Resistance Level $2.17 $1.98
Average True Range (ATR) 0.13 0.12
MACD 0.05 -0.00
Stochastic Oscillator 89.00 31.22

Price Performance

Historical Comparison
BTMD
BTCS

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About BTCS BTCS Inc.

BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.

Share on Social Networks: